Screener
TransCode Therapeutics, Inc. RNAZ Q3 2025 earnings
Reported November 14, 2025 · Before market open
EPS-$5.49Beat by $3.75
EPS estimate-$9.24
Next report
Aug 18, 2026 (In 6 days)Versus estimates
Diluted EPS
FAQ
- When did TransCode Therapeutics, Inc. report Q3 2025 earnings?
- TransCode Therapeutics, Inc. (RNAZ) reported Q3 2025 earnings on November 14, 2025 before market open.
- What were TransCode Therapeutics, Inc.'s Q3 2025 revenue and EPS?
- TransCode Therapeutics, Inc. reported eps of $-5.49 for Q3 2025.
- Did TransCode Therapeutics, Inc. beat estimates in Q3 2025?
- EPS beat the consensus estimate of $-9.24 by $3.75.
- How did TransCode Therapeutics, Inc.'s Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 4.0% from $-5.28.
- Where can I find TransCode Therapeutics, Inc.'s Q3 2025 SEC filings?
- You can read the 10-Q periodic report (0001829635-25-000004) directly on SEC EDGAR. The filing index links above go to sec.gov.
